Brain scans may end guesswork in treating stubborn depression
NCT ID NCT07680140
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests whether brain imaging and clinical data can help select the best treatment for people with depression that hasn't improved with standard therapies. Participants receive either repetitive transcranial magnetic stimulation (rTMS) or ketamine, and researchers check if certain biomarkers predict who responds better to which option. The goal is to develop a tool that speeds up effective treatment and reduces the trial-and-error process.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
rTMS (brain stimulation) and ketamine (medication)
What this could lead to
If successful, this approach could help doctors quickly match people with treatment-resistant depression to the therapy most likely to work for them, reducing trial-and-error.
What could go wrong
This is a small pilot study with only 27 participants, so results may not apply broadly. The biomarker tool may not reliably predict responses, and both rTMS and ketamine have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT DEPRESSION (TRD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain Stimulation for Bipolar Depression Trial | NCT07680153
- TMS and Biomarkers in Treatment-Resistant Depres NCT07673913
- Vagus Nerve Stimulation for Resistant Depression NCT05952674
- Nature-Based Therapy for Anxiety, Depression & S NCT06981000
- Depression, Exercise & Autophagy Study (NCT07664540)
- Ketamine for Chronic Pain: Observational Registr NCT07648771
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••